•
Dec 31, 2019

REGENXBIO Q4 2019 Earnings Report

Total Revenue
$11.8M
Previous year: $40.8M
-71.1%
EPS
-$0.72
Previous year: $0.11
-754.5%
Gross Profit
$7.98M
Previous year: $37.9M
-79.0%
Cash and Equivalents
$69.5M
Previous year: $75.6M
-8.0%
Free Cash Flow
-$26.5M
Previous year: -$9.03M
+193.9%
Total Assets
$498M
Previous year: $544M
-8.4%

REGENXBIO

REGENXBIO